Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 1 - 10 of 200 for nvs. (0.07 seconds)

Second time around for this innovative company. More...
Sanofi-Synthelabo. More details...
VEGF Trap in Phase I clinical trials with Aventis. More...
Global generics company beats estimates. More details...
Generic drug maker on a roll. More details...
Why science works, but not as quickly as you want it to....
It will be hot in New Orleans this June, and we don't...
See Personalized Medicine: Wishful Thinking? (Part 1)....
Four U.S. biotechs receive more than $25MM for clinical...
Considered by NCI to be a "national priority,"...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital